Coverage of influenza vaccination and influencing factors among healthcare workers in Shandong Province, China, 2021-2022.

Yuwei Liu, Ti Liu, Mingxiao Yao, Qiang Wang, Renpeng Li, Zengqiang Kou
Author Information
  1. Yuwei Liu: College of Public Health, Shandong Second Medical University, Shandong, China.
  2. Ti Liu: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Disease Prevention and Control, Jinan, China.
  3. Mingxiao Yao: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Disease Prevention and Control, Jinan, China.
  4. Qiang Wang: College of Public Health, Shandong Second Medical University, Shandong, China.
  5. Renpeng Li: Shandong Provincial Center for Health Science & Technology and Talents Development, Shandong, China.
  6. Zengqiang Kou: Shandong Center for Disease Control and Prevention, Shandong Provincial Key Laboratory of Infectious Disease Prevention and Control, Jinan, China.

Abstract

Healthcare workers (HCWs) are at increased risk of exposure to the influenza virus in their daily clinical and disease prevention activities, making them a high-risk group for influenza infection. However, the vaccination rate among HCWs has always been low. This study investigated influenza vaccination uptake and willingness among HCWs in the context of the COVID-19 pandemic. The analysis revealed that the influenza vaccination uptake among HCWs was 67.5%, with 79.6% willing to receive the influenza vaccine in 2022/2023 A significant majority (92.7%) agreed that the COVID-19 pandemic increased their willingness to receive the influenza vaccine, and 94.8% agreed with the necessity of receiving the influenza vaccine even after COVID-19 vaccination. Binary logistic regression model identified key factors that influence vaccination intentions. HCWs who perceived a high risk of influenza and its threat to health, found vaccination convenient, and believed in the safety of the influenza vaccine were more likely to be vaccinated. Conversely, the high price of the influenza vaccine was a barrier, whereas those who considered the vaccine affordable were more likely to be vaccinated. Although Changchun Changsheng vaccine incident (The Changchun Changsheng Biotechnology Company was found to have violated good manufacturing practices in 2018, leading to widespread distribution of subpotent vaccines in China.) may not significantly impact the vaccination uptake among healthcare workers, some HCWs still harbor doubts about vaccine safety, which remains a key reason for vaccine hesitancy. This study emphasizes the importance of the strict monitoring and management of vaccines, conducting clinical studies to support vaccine safety, and implementing free influenza vaccine policies, workplace vaccination requirements, and organized mass vaccinations. Educational efforts to increase HCWs' understanding of influenza and influenza vaccines are crucial to increasing vaccination uptake. Furthermore, implementing comprehensive intervention measures is essential to effectively improve the influenza vaccination uptake.

Keywords

References

  1. MMWR Recomm Rep. 2007 Jun 22;56(RR-4):1-40 [PMID: 17585291]
  2. J Clin Nurs. 2016 Sep;25(17-18):2502-10 [PMID: 27364683]
  3. Int J Infect Dis. 2020 Apr;93:375-387 [PMID: 32109627]
  4. Hum Vaccin Immunother. 2021 Jul 3;17(7):2185-2189 [PMID: 33497309]
  5. Vaccine. 2020 Nov 3;38(47):7464-7471 [PMID: 33041097]
  6. Int J Infect Dis. 2022 Dec;125:153-163 [PMID: 36328290]
  7. Infect Dis Poverty. 2022 Oct 8;11(1):105 [PMID: 36209258]
  8. Vaccine. 2019 Feb 21;37(9):1168-1173 [PMID: 30709722]
  9. J Integr Med. 2021 Nov;19(6):503-514 [PMID: 34544670]
  10. Vaccine. 2020 Jul 22;38(34):5430-5435 [PMID: 32620371]
  11. BMJ Open. 2020 Jun 15;10(6):e035703 [PMID: 32540890]
  12. Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544 [PMID: 36456484]
  13. PLoS One. 2017 Jan 26;12(1):e0170550 [PMID: 28125629]
  14. China CDC Wkly. 2021 Oct 29;3(44):918-922 [PMID: 34745692]
  15. Sci Rep. 2019 Dec 23;9(1):19650 [PMID: 31873144]
  16. Hum Vaccin Immunother. 2022 Nov 30;18(6):2102354 [PMID: 35920744]
  17. Infect Control Hosp Epidemiol. 2010 Oct;31(10):987-95 [PMID: 20807037]
  18. N Engl J Med. 2021 Feb 4;384(5):393-396 [PMID: 33535287]
  19. J Glob Health. 2020 Dec;10(2):021102 [PMID: 33312512]
  20. PLoS One. 2018 Jun 7;13(6):e0198685 [PMID: 29879206]
  21. Hum Vaccin Immunother. 2021 Feb 1;17(2):465-474 [PMID: 32750258]
  22. Vaccine. 2018 Jun 22;36(27):3960-3966 [PMID: 29801998]
  23. Expert Rev Vaccines. 2019 Jan;18(1):5-13 [PMID: 30501454]
  24. Vaccines (Basel). 2019 Dec 26;8(1): [PMID: 31887994]
  25. Vaccine X. 2019 Jul 11;2:100036 [PMID: 31384750]
  26. Lancet. 2018 Mar 31;391(10127):1285-1300 [PMID: 29248255]
  27. MMWR Morb Mortal Wkly Rep. 2015 Sep 18;64(36):993-9 [PMID: 26389743]
  28. Front Public Health. 2021 Mar 25;9:570098 [PMID: 33842415]
  29. Zhonghua Yi Xue Za Zhi. 2021 Mar 2;101(8):560-567 [PMID: 33663186]
  30. Curr Opin Infect Dis. 2010 Aug;23(4):293-9 [PMID: 20592530]
  31. Health Aff (Millwood). 2016 Feb;35(2):284-92 [PMID: 26858382]
  32. J Infect. 2010 Sep;61(3):252-8 [PMID: 20600304]
  33. MMWR Morb Mortal Wkly Rep. 2017 Sep 29;66(38):1009-1015 [PMID: 28957042]

MeSH Term

Humans
Influenza Vaccines
Health Personnel
China
Influenza, Human
Male
Female
Adult
Vaccination Coverage
Middle Aged
COVID-19
Vaccination
Surveys and Questionnaires
Health Knowledge, Attitudes, Practice
Young Adult

Chemicals

Influenza Vaccines

Word Cloud

Created with Highcharts 10.0.0influenzavaccinationvaccineHCWsamonguptakeworkersCOVID-19safetyvaccineshealthcareincreasedriskclinicalstudywillingnesspandemicreceiveagreedkeyfactorshighfoundlikelyvaccinatedChangchunChangshengChinaimplementingHealthcareexposurevirusdailydiseasepreventionactivitiesmakinghigh-riskgroupinfectionHoweverratealwayslowinvestigatedcontextanalysisrevealed675%796%willing2022/2023significantmajority927%948%necessityreceivingevenBinarylogisticregressionmodelidentifiedinfluenceintentionsperceivedthreathealthconvenientbelievedConverselypricebarrierwhereasconsideredaffordableAlthoughincidentBiotechnologyCompanyviolatedgoodmanufacturingpractices2018leadingwidespreaddistributionsubpotentmaysignificantlyimpactstillharbordoubtsremainsreasonhesitancyemphasizesimportancestrictmonitoringmanagementconductingstudiessupportfreepoliciesworkplacerequirementsorganizedmassvaccinationsEducationaleffortsincreaseHCWs'understandingcrucialincreasingFurthermorecomprehensiveinterventionmeasuresessentialeffectivelyimproveCoverageinfluencingShandongProvince2021-2022Influenza

Similar Articles

Cited By